Dermatology News and Research

Latest Dermatology News and Research

EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy

GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Commission has granted marketing authorisation for Trobalt as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.

30 Mar 2011

EndyMed's 3DEEP RF technology in real-time skin impedance measurements published in peer reviewed paper

EndyMed Medical, Ltd., a leader in the use of multi-source radiofrequency for professional aesthetic treatments, announced today the publication of the latest peer reviewed paper on 3DEEP radiofrequency technology, "A novel method for real-time skin impedance measurement during radiofrequency skin tightening treatments".

24 Mar 2011

Insight into 'contagious itch'

Can you catch an itch? The answer is yes. Dermatologist Gil Yosipovitch, M.D., of Wake Forest Baptist Medical Center, has been researching what's known as "contagious itch."

23 Mar 2011

Experts to showcase nursing education, practical innovations at Las Vegas national conference

Motivating and educating nurses to help them excel in their daily practice is the focus of this year's National Conference for Nurse Practitioners: The Conference for Primary and Acute Care Clinicians, May 11-14, 2011, at the Las Vegas Hilton in Las Vegas, NV.

22 Mar 2011

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

If a big bunch of your brain cells suddenly went rogue and decided to become fat cells, it could cloud your decision-making capacity a bit. Fortunately, early in an organism's development, cells make firm and more-or-less permanent decisions about whether they will live their lives as, say, skin cells, brain cells or, well, fat cells.

21 Mar 2011

KYTHERA presents additional data from third ATX-101 Phase II clinical study in submental fat reduction

KYTHERA Biopharmaceuticals, Inc. today presented additional efficacy data from a third Phase II clinical study with ATX-101, a first-in-class adipolytic agent that is under investigation for the reduction of submental ('under the chin') fat. The expanded analysis focused on additional patient reported outcome measures, including instruments measuring submental fat impact, subject global assessments and subject self-ratings of chin attractiveness.

18 Mar 2011

BUSM scientists identify new biomarker and melanoma treatment target

Researchers at Boston University School of Medicine, in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma.

18 Mar 2011

RBMG selects Dynatronics for inclusion in the RB Milestone Portfolio

Dynatronics Corporation announced that it has been selected for inclusion in the RB Milestone Portfolio, a group of companies selected by RB Milestone Group, LLC, to be introduced to the market via a combination of traditional and innovative analytical and communication strategies including equity research, The Portal Network, and non-deal roadshows, with a focus on the healthcare, mining, energy, and technology sectors.

17 Mar 2011

Electric devices can improve aging skin

It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.

16 Mar 2011

Non-laser light treatments may help treat common skin conditions

While dermatologists have used lasers successfully for years to treat common skin conditions such as acne, rosacea and aging skin, it now appears that even non-laser lights may provide some of the same benefits.

16 Mar 2011

First ever light-activated, non-surgical treatment for HPV and pre-cancerous lesions of the cervix

A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.

16 Mar 2011

Psychological disorders may be more prevalent in adolescent acne patients

America's prom season is on the horizon and with it comes distress for thousands of teens who will be distraught to see a pimple raise its ugly head on their nose or chin.

16 Mar 2011

Peanut allergy has a genetic link: Study

A new study suggests that children with a certain gene defect are more likely to develop a peanut allergy. They studied the effect of changes in the gene filaggrin, which helps the skin block out allergens. They noted what has been seen before – the changes in the gene reduce the effectiveness of the barrier, increasing the risk for eczema and asthma.

14 Mar 2011

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

Personal usage and patient recommendations for dietary supplements are quite common across specialties

For physicians within several medical specialties, including dermatology, cardiology and orthopedics, personal usage of and patient recommendations for dietary supplements are quite common-, according to a study published in Nutrition Journal, a peer-reviewed, on-line journal that focuses on the field of human nutrition.

11 Mar 2011

Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.

10 Mar 2011

LRI announces 12 new research grants to drive innovation in lupus

The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.

9 Mar 2011

Fumaric acid salts may protect against Multiple Sclerosis

Fumaric acid salts have been in use against severe psoriasis for a long time. About ten years ago, researchers in Bochum speculated that they may also have a favourable effect on Multiple Sclerosis as a result of their TH2 polarizing mechanisms.

8 Mar 2011

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

AstraZeneca and Galderma Pharma S.A., a global speciality pharmaceutical company focused on dermatology, today announced they have entered into a R&D collaboration to develop new treatments for dermatological conditions including psoriasis, acne and atopic dermatitis which significantly affect the health and quality of life for millions of people worldwide.

7 Mar 2011

Scientist discovers new mechanism for regulation of gene expression

Dr. David Levin, Professor of Molecular & Cell Biology at Boston University Henry M. Goldman School of Dental Medicine and Professor of Microbiology at Boston University School of Medicine discovered recently a novel, evolutionarily conserved mechanism for the regulation of gene expression.

4 Mar 2011

Dermatology News and Research

Latest Dermatology News and Research

EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy

EndyMed's 3DEEP RF technology in real-time skin impedance measurements published in peer reviewed paper

Insight into 'contagious itch'

Experts to showcase nursing education, practical innovations at Las Vegas national conference

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

KYTHERA presents additional data from third ATX-101 Phase II clinical study in submental fat reduction

BUSM scientists identify new biomarker and melanoma treatment target

RBMG selects Dynatronics for inclusion in the RB Milestone Portfolio

Electric devices can improve aging skin

Non-laser light treatments may help treat common skin conditions

First ever light-activated, non-surgical treatment for HPV and pre-cancerous lesions of the cervix

Psychological disorders may be more prevalent in adolescent acne patients

Peanut allergy has a genetic link: Study

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Personal usage and patient recommendations for dietary supplements are quite common across specialties

Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

LRI announces 12 new research grants to drive innovation in lupus

Fumaric acid salts may protect against Multiple Sclerosis

Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders

Scientist discovers new mechanism for regulation of gene expression

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dermatology News and Research

Latest Dermatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in